放射性脑损伤诊治中国专家共识

2019-06-30 中国医师协会神经内科医师分会 中华神经医学杂志.2019.18(6):541-549. 发表于上海

为促进放射性脑损伤相关的放射治疗学、神经病学等相关专业临床医师对放射性脑损伤的关注和认识,针对诊断与治疗做出正确决策,中国放射性脑损伤多学科协作组、中国医师协会神经内科医师分会脑与脊髓损害专委会联合相关的肿瘤放疗科、神经外科、神经影像专家就上述问题展开讨论。并结合目前国内外现有研究和临床证据,就放射性脑损伤的临床诊疗相关原则达成共识。

中文标题:

放射性脑损伤诊治中国专家共识

发布日期:

2019-06-30

简要介绍:

为促进放射性脑损伤相关的放射治疗学、神经病学等相关专业临床医师对放射性脑损伤的关注和认识,针对诊断与治疗做出正确决策,中国放射性脑损伤多学科协作组、中国医师协会神经内科医师分会脑与脊髓损害专委会联合相关的肿瘤放疗科、神经外科、神经影像专家就上述问题展开讨论。并结合目前国内外现有研究和临床证据,就放射性脑损伤的临床诊疗相关原则达成共识。

拓展指南:放射相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=放射性脑损伤诊治中国专家共识)] GetToolGuiderByIdResponse(projectId=1, id=d496b1c001e72852, title=放射性脑损伤诊治中国专家共识, enTitle=, guiderFrom=中华神经医学杂志.2019.18(6):541-549., authorId=null, author=, summary=为促进放射性脑损伤相关的放射治疗学、神经病学等相关专业临床医师对放射性脑损伤的关注和认识,针对诊断与治疗做出正确决策,中国放射性脑损伤多学科协作组、中国医师协会神经内科医师分会脑与脊髓损害专委会联合相关的肿瘤放疗科、神经外科、神经影像专家就上述问题展开讨论。并结合目前国内外现有研究和临床证据,就放射性脑损伤的临床诊疗相关原则达成共识。 , cover=https://img.medsci.cn/202301015/1697393510287_4754896.jpeg, journalId=null, articlesId=null, associationId=1243, associationName=中国医师协会神经内科医师分会, associationIntro=, copyright=0, guiderPublishedTime=Sun Jun 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>为促进放射性脑损伤相关的放射治疗学、神经病学等相关专业临床医师对放射性脑损伤的关注和认识,针对诊断与治疗做出正确决策,中国放射性脑损伤多学科协作组、中国医师协会神经内科医师分会脑与脊髓损害专委会联合相关的肿瘤放疗科、神经外科、神经影像专家就上述问题展开讨论。并结合目前国内外现有研究和临床证据,就放射性脑损伤的临床诊疗相关原则达成共识。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>放射</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=40eb41c001e6208b" title="前列腺癌放射治疗安全共识" target=_blank>前列腺癌放射治疗安全共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=bc2031c001e562b5" title="2019 ASGE指南:内镜检查在慢性放射性直肠病出血中的作用" target=_blank>2019 ASGE指南:内镜检查在慢性放射性直肠病出血中的作用</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=cac7c1c001ea884d" title="2019 FROGG建议:淋巴结阳性前列腺癌的放射治疗" target=_blank>2019 FROGG建议:淋巴结阳性前列腺癌的放射治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b5e621c001ea14b8" title="2019 ESTRO共识指南:早期乳腺癌基于植入物的即时乳房重建术后放射治疗靶区勾画" target=_blank>2019 ESTRO共识指南:早期乳腺癌基于植入物的即时乳房重建术后放射治疗靶区勾画</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=67c2b1c00169102f" title="中国放射性直肠炎诊治专家共识(2018版)" target=_blank>中国放射性直肠炎诊治专家共识(2018版)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E6%94%BE%E5%B0%84" target=_blank>有关放射更多指南</a></ul>, tagList=[TagDto(tagId=92713, tagName=放射性脑损伤)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6699, appHits=219, showAppHits=0, pcHits=3944, showPcHits=3514, likes=105, shares=8, comments=5, approvalStatus=1, publishedTime=Tue Jul 30 00:29:12 CST 2019, publishedTimeString=2019-06-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Tue Jul 30 00:29:12 CST 2019, updatedBy=8538692, updatedName=梅斯话题小助手, updatedTime=Wed Mar 06 17:49:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=放射性脑损伤诊治中国专家共识)])
放射性脑损伤诊治中国专家共识
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1216633, encodeId=6439121663397, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a48f5198076, createdName=1472f0d8m19暂无昵称, createdTime=Tue May 03 19:51:30 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053131, encodeId=77b9105313183, content=受益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210919/eda6d89e8b29459798c3dfcc35631a39/70d080d25ca34023b78b7063257d9339.jpg, createdBy=00545572433, createdName=ms4000002042870312, createdTime=Sun Sep 19 21:54:35 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011760, encodeId=28111011e60e2, content=学习了,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/qKhKjlGb3Qsm2RbT5QuEdv3PaWyWa6vVgX1cQ4ZDTQPiarNWy2D6g7XqqDdq8UYKBZ2SMAr5oJfIQTJLKxGm90Q/0, createdBy=b0422198623, createdName=志, createdTime=Thu Aug 26 17:58:11 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906165, encodeId=c0d990616537, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 21:30:59 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2022-05-03 1472f0d8m19暂无昵称

    好东西

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1216633, encodeId=6439121663397, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a48f5198076, createdName=1472f0d8m19暂无昵称, createdTime=Tue May 03 19:51:30 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053131, encodeId=77b9105313183, content=受益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210919/eda6d89e8b29459798c3dfcc35631a39/70d080d25ca34023b78b7063257d9339.jpg, createdBy=00545572433, createdName=ms4000002042870312, createdTime=Sun Sep 19 21:54:35 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011760, encodeId=28111011e60e2, content=学习了,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/qKhKjlGb3Qsm2RbT5QuEdv3PaWyWa6vVgX1cQ4ZDTQPiarNWy2D6g7XqqDdq8UYKBZ2SMAr5oJfIQTJLKxGm90Q/0, createdBy=b0422198623, createdName=志, createdTime=Thu Aug 26 17:58:11 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906165, encodeId=c0d990616537, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 21:30:59 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2021-09-19 ms4000002042870312

    受益很大

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1216633, encodeId=6439121663397, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a48f5198076, createdName=1472f0d8m19暂无昵称, createdTime=Tue May 03 19:51:30 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053131, encodeId=77b9105313183, content=受益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210919/eda6d89e8b29459798c3dfcc35631a39/70d080d25ca34023b78b7063257d9339.jpg, createdBy=00545572433, createdName=ms4000002042870312, createdTime=Sun Sep 19 21:54:35 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011760, encodeId=28111011e60e2, content=学习了,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/qKhKjlGb3Qsm2RbT5QuEdv3PaWyWa6vVgX1cQ4ZDTQPiarNWy2D6g7XqqDdq8UYKBZ2SMAr5oJfIQTJLKxGm90Q/0, createdBy=b0422198623, createdName=志, createdTime=Thu Aug 26 17:58:11 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906165, encodeId=c0d990616537, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 21:30:59 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2021-08-26

    学习了,很实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1216633, encodeId=6439121663397, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a48f5198076, createdName=1472f0d8m19暂无昵称, createdTime=Tue May 03 19:51:30 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053131, encodeId=77b9105313183, content=受益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210919/eda6d89e8b29459798c3dfcc35631a39/70d080d25ca34023b78b7063257d9339.jpg, createdBy=00545572433, createdName=ms4000002042870312, createdTime=Sun Sep 19 21:54:35 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011760, encodeId=28111011e60e2, content=学习了,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/qKhKjlGb3Qsm2RbT5QuEdv3PaWyWa6vVgX1cQ4ZDTQPiarNWy2D6g7XqqDdq8UYKBZ2SMAr5oJfIQTJLKxGm90Q/0, createdBy=b0422198623, createdName=志, createdTime=Thu Aug 26 17:58:11 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906165, encodeId=c0d990616537, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da31896401, createdName=ms3234097737105654, createdTime=Tue Dec 08 21:30:59 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2020-12-08 ms3234097737105654

    好东西

    0